Your browser doesn't support javascript.
loading
Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals.
Abdulrehman, Jameel; Zarabi, Sahar; Elbaz, Carolyne; de Wit, Kerstin; Lin, Yulia; Sholzberg, Michelle; Selby, Rita.
Afiliação
  • Abdulrehman J; Division of Hematology Department of Medicine University Health Network University of Toronto Toronto ON Canada.
  • Zarabi S; University of Toronto Medical School Toronto ON Canada.
  • Elbaz C; Department of Medicine McGill University Montreal QC Canada.
  • de Wit K; Department of Medicine and Department of HEI McMaster University Hamilton ON Canada.
  • Lin Y; Department of Emergency Medicine Queen's University Kingston ON Canada.
  • Sholzberg M; Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Centre Toronto ON Canada.
  • Selby R; Department of Laboratory Medicine & Pathobiology University of Toronto Toronto ON Canada.
Res Pract Thromb Haemost ; 5(5): e12535, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34401639
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2021 Tipo de documento: Article